The acquisition, which is similar to its purchase of Thyrocare in June, is part of the Mumbai-based company’s plans to position itself as a broader online healthcare firm, diversifying from being just an online medicine delivery platform.
from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2XkUpLT
via IFTTT
Home »
Healthcare/Biotech-Industry-Economic Times
» PharmEasy acquires Aknamed in $180-$190 million stock deal
0 comments:
Post a Comment